Preclinical Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.

13 Students Among 40 Finalists In Regeneron Science Talent Search.

To test new stroke treatments, a research team from the Keck School of Medicine of USC develops a more rigorous system for conducting preclinical research that could lead to more successful clinical trials.

Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows.

Walking into the Kay Bailey Hutchison Convention Center in Dallas for the Regeneron International Science and Engineering Fair, Aditi Avinash was overcome with nerves, but when she left, she took home an award and scholarship.